Tuttle Capital Management, LLC Dexcom Inc Transaction History

Tuttle Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$95.51 - $112.95 $101,145 - $119,614	-1,059 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$62.68 - $105.34 $66,378 - $111,555	1,059 New	1,059 $429,000
Q3 2019 Oct 18, 2019	SELL	$35.53 - $43.8 $383,226 - $472,426	-10,786 Closed	0 $0
Q2 2019 Jul 29, 2019	BUY	$27.84 - $38.92 $300,282 - $419,791	10,786 New	10,786 $1.62 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $28.8B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Tuttle Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Tuttle Capital Management, LLC with notifications on news.